Read articles from Global

July 27, 2026 by substack.com

Power, temperature and device design are often discussed as if they automatically translate into higher danger. With sub-ohm vaping, the more important question is what the evidence actually shows about emissions, exposure and real-world use. High-powered devices should be assessed carefully, but not through assumptions that ignore how experienced users control settings, airflow and liquid consumption. Safety debates need measurements, context and comparison with the risks of continued smoking.

July 24, 2026 by gfn.tv

Smoking among people who use drugs, such as heroin users in England, contributes significantly to premature deaths. Despite this, smoking is often overlooked in drug treatment services. David MacKintosh from the Global State of Tobacco Harm Reduction suggests incorporating safer nicotine options to improve health outcomes and longevity. Drug service providers face challenges in addressing smoking alongside drug issues due to resource constraints. Encouraging harm reduction services to consider smoking cessation could yield positive results. Smoking-related deaths in this population are comparable to drug-related deaths, highlighting the need for comprehensive support and awareness. The Global Forum on Nicotine fosters discussions on harm reduction approaches with a focus on consumer perspectives.

July 24, 2026 by clearingtheair.eu

Heart risk is not shaped by nicotine alone. A review linking full switching from smoking to vaping with lower cardiovascular risk reinforces the central point of harm reduction: combustion is the major driver of disease. The distinction between dual use and complete switching also matters, because public health gains depend on moving away from cigarettes, not simply adding another product. Risk communication should be clear enough to help smokers understand that difference.

July 23, 2026 by substack.com

Doubt can be manufactured in more than one direction. In nicotine policy, selective evidence and repeated uncertainty can make lower-risk products appear more dangerous than they are, while the risks of continued smoking fade into the background. That matters because public understanding shapes regulation, and regulation shapes whether smokers see switching as credible. Public health should challenge misinformation without becoming a source of it.

July 23, 2026 by vapingpost.com

Public health authorities are reevaluating nicotine regulation as smoking rates decline worldwide. The focus shifts towards safer oral nicotine pouches as an alternative to vapes. The debate emphasizes managing risks proportionately and avoiding past mistakes. US regulators approved nicotine pouches under a harm reduction context. Studies show pouch users are mainly trying to quit smoking. Concerns about youth uptake and oral health effects persist. Transparent risk communication is crucial. Innovations in product design aim to reduce oral irritation. Regulators face challenges in balancing access for adult smokers and preventing youth uptake. Nicotine pouches are recognized as a harm reduction tool compared to cigarettes, highlighting the need for evidence-based regulation promoting both protection and progress.

July 21, 2026 by gfn.tv

Bad evidence can become powerful when it is used to justify prohibition. Studies with weak methods, selective comparisons or inflated claims can shape policy long after their limitations are forgotten. That matters in nicotine regulation, where fear-based science can make lower-risk products look more dangerous than they are and keep smokers away from switching. Public health should challenge poor evidence before it becomes law.

July 17, 2026 by gfn.tv

Prohibition often looks clean on the surface: ban the product, remove the problem. Beneath it sits a messier reality — demand, dependence, informal supply and people pushed further from safer choices. In tobacco and nicotine policy, bans can make harm harder to see rather than easier to reduce. The question is not whether prohibition sounds strong, but what it leaves behind when the headlines fade.

July 17, 2026 by substack.com

Youth protection is essential, but it should not be used as a blanket argument against harm reduction for adults. Policies aimed at preventing underage use need to be judged by evidence, not assumptions about what sounds protective. If restrictions make safer nicotine products harder for adult smokers to access, they may create new harms while doing little to address the real drivers of youth use. Good policy can protect young people without closing the door on adults trying to leave cigarettes behind.

July 16, 2026 by dcjournal.com

The forgotten smoker is not the one who refuses to listen. It is the person who has heard every warning, tried to quit, and still finds cigarettes hard to leave behind. Public health cannot stop at telling people what they already know; it must offer routes that are realistic enough to use. Safer nicotine alternatives matter because they may reach the people traditional tobacco control keeps missing.

July 13, 2026 by gfn.tv

Flavour bans promise simple solutions, but the real-world evidence is far less convincing. When smoke-free products become less appealing or harder to access, adult smokers may lose one of the reasons switching away from cigarettes works. Youth protection should be taken seriously, but policy must also consider unintended consequences: illicit markets, reduced switching and a return to smoking. A ban is not a success if it removes options without reducing harm.